| Read the latest news and updates from NCATS. | Is this email not displaying correctly? View it in your browser. |
|---|
| Volume 09 │ Issue 10 │ Oct. 29, 2020 |
|
Director’s Message
|
In his latest message, the director discusses NCATS’ commitment to reducing COVID-19 health disparities and highlights how CTSA Program hub resources are being leveraged to support NIH’s CEAL initiative and RADx-UP program. |
What's Happening
|
COVID-19 Cytokine Storm: Clinical Trial Begins Testing Immune Modulators as TreatmentLearn about the key roles NCATS and its CTSA Program are playing in a new large-scale clinical trial to evaluate the safety and efficacy of immune modulator drugs in hospitalized adults with COVID-19, as part of the NIH ACTIV partnership. |
|
New Video Series Highlights the Work of Translational Scientists During the PandemicWatch this collection of videos from translational scientists to learn about their research and what inspires them in their work. |
|
NCATS Team Uncovers Promising Therapies for MyositisDiscover what approach a team of NCATS researchers used to identify promising therapies for myositis, a rare muscle disease. |
|
Translational Science Training Program Preps the Next Generation of ScientistsRead a review about how fellows who completed NCATS’ DPI training program experienced early research successes and pursued a broad range of science-based careers at the benchtop and beyond. |
Announcements & Opportunities
|
|
|
|
|
|
Meet NCATS Staff
|
Ewy A. Mathé, Ph.D.
|
|
Terrence E. Rudd, Jr., M.A.
|
Contact Us
National Center for Advancing Translational Sciences
National Institutes of Health
6701 Democracy Boulevard, 9th Floor
Bethesda, MD 20892
For language access assistance, contact the NCATS Public Information Officer.
To view previous newsletters, click here.
|
